Neurocrine Biosciences, Inc.
MX ˙ BMV ˙ US64125C1099
SecurityMX:NBIX / Neurocrine Biosciences, Inc.
InstitutionLazard Asset Management Llc
Latest Disclosed Ownership124,479 shares
Latest Disclosed Value $ 16,398,863
Lazard Asset Management Llc reports 91.73% increase in ownership of NBIX / Neurocrine Biosciences, Inc.

On May 15, 2026 - Lazard Asset Management Llc filed a 13F-HR form disclosing ownership of 124,479 shares of Neurocrine Biosciences, Inc. (MX:NBIX) valued at $16,398,863 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 64,925 shares of Neurocrine Biosciences, Inc.. This represents a change in shares of 91.73% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 124,479 59,554 91.73 16,399 78.08 0.0141
2026-02-17 2025-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 64,925 24,048 58.83 9,208 60.47 0.0156
2025-11-14 2025-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 40,877 4,503 12.38 5,738 143,350.00 0.0077
2025-08-14 2025-06-30 13F NEUROCINE BIO Common Stock 64125C109 36,374 -20,408 -35.94 5 -33.33 0.0063
2025-05-15 2025-03-31 13F NEUROCINE BIO Common Stock 64125C109 56,782 -2,497 -4.21 6 -25.00 0.0096
2025-02-14 2024-12-31 13F NEUROCINE BIO Common Stock 64125C109 59,279 -15,643 -20.88 8 0.00 0.0118
2024-11-14 2024-09-30 13F NEUROCINE BIO Common Stock 64125C109 74,922 13,489 21.96 9 0.00 0.0115
2024-08-14 2024-06-30 13F NEUROCINE BIO Common Stock 64125C109 61,433 6,104 11.03 8 14.29 0.0106
2024-07-09 2024-03-31 13F/A-1 NEUROCINE BIO Common Stock 64125C109 55,329 8,884 19.13 8 16.67 0.0093
2024-05-14 2024-03-31 13F NEUROCINE BIO Common Stock 64125C109 55,329 8,884 8 0.0093
2024-02-14 2023-12-31 13F NEUROCINE BIO Common Stock 64125C109 46,445 19,192 70.42 6 100.00 0.0077
2023-11-14 2023-09-30 13F NEUROCINE BIO Common Stock 64125C109 27,253 25,393 1,365.22 3 0.0042
2023-08-15 2023-06-30 13F NEUROCINE BIO Common Stock 64125C109 1,860 -43,127 -95.87 0 -100.00 0.0002
2023-05-15 2023-03-31 13F NEUROCINE BIO Common Stock 64125C109 44,987 40,752 962.27 5 -99.21 0.0060
2023-02-15 2022-12-31 13F NEUROCINE BIO Common Stock 64125C109 4,235 3,032 252.04 505 297.64 0.0007
2022-11-14 2022-09-30 13F NEUROCINE BIO Common Stock 64125C109 1,203 438 57.25 127 71.62 0.0002
2022-08-09 2022-06-30 13F NEUROCINE BIO Common Stock 64125C109 765 -26 -3.29 74 0.00 0.0001
2022-05-13 2022-03-31 13F NEUROCINE BIO Common Stock 64125C109 791 -47,717 -98.37 74 -98.21 0.0001
2022-02-09 2021-12-31 13F NEUROCINE BIO Common Stock 64125C109 48,508 14,394 42.19 4,131 26.29 0.0044
2021-11-15 2021-09-30 13F NEUROCINE BIO Common Stock 64125C109 34,114 34,114 3,271 0.0037
2021-08-12 2021-06-30 13F NEUROCINE BIO Common Stock 64125C109 0 -915 -100.00 0 -100.00
2021-05-14 2021-03-31 13F NEUROCINE BIO Common Stock 64125C109 915 -73 -7.39 88 -6.38 0.0001
2021-02-11 2020-12-31 13F NEUROCINE BIO Common Stock 64125C109 988 28 2.92 94 2.17 0.0001
2020-11-13 2020-09-30 13F NEUROCINE BIO Common Stock 64125C109 960 -212 -18.09 92 -35.21 0.0001
2020-08-13 2020-06-30 13F NEUROCINE BIO Common Stock 64125C109 1,172 -641 -35.36 142 -8.97 0.0002
2020-05-14 2020-03-31 13F NEUROCINE BIO Common Stock 64125C109 1,813 1,259 227.26 156 164.41 0.0003
2020-02-13 2019-12-31 13F NEUROCINE BIO Common Stock 64125C109 554 -886 -61.53 59 -54.26 0.0001
2019-11-14 2019-09-30 13F NEUROCINE BIO Common Stock 64125C109 1,440 340 30.91 129 40.22 0.0002
2019-08-14 2019-06-30 13F NEUROCINE BIO Common Stock 64125C109 1,100 0 0.00 92 -4.17 0.0001
2019-08-28 2019-03-31 13F/A-1 NEUROCINE BIO Common Stock 64125C109 1,100 0 0.00 96 23.08 0.0002
2019-05-13 2019-03-31 13F NEUROCINE BIO Common Stock 64125C109 1,100 0 96
2019-08-28 2018-12-31 13F/A-1 NEUROCINE BIO Common Stock 64125C109 1,100 1,100 78 0.0001
2019-02-13 2018-12-31 13F NEUROCINE BIO Common Stock 64125C109 1,100 1,100 78
2019-08-30 2018-09-30 13F/A-1 NEUROCINE BIO Common Stock 64125C109 0 -10,534 -100.00 0 -100.00
2019-08-30 2018-06-30 13F/A-1 NEUROCINE BIO Common Stock 64125C109 10,534 10,534 1,034 0.0018
2018-08-13 2018-06-30 13F NEUROCINE BIO Common Stock 64125C109 10,534 10,534 1,034
2019-08-19 2017-06-30 13F/A-1 NEUROCINE BIO Common Stock 64125C109 0 -12,700 -100.00 0 -100.00
2019-08-13 2017-03-31 13F/A-1 NEUROCINE BIO Common Stock 64125C109 12,700 -1,500 -10.56 549 0.00 0.0010
2017-05-12 2017-03-31 13F NEUROCINE BIO Common Stock 64125C109 12,700 8,100 549
2019-07-30 2016-12-31 13F/A-1 NEUROCINE BIO Common Stock 64125C109 14,200 -34,443 -70.81 549 -77.70 0.0011
2017-02-13 2016-12-31 13F NEUROCINE BIO Common Stock 64125C109 4,600 -44,043 178
2019-08-07 2016-09-30 13F/A-1 NEUROCINE BIO Common Stock 64125C109 48,643 -19,041 -28.13 2,462 -19.96 0.0049
2016-11-14 2016-09-30 13F NEUROCINE BIO Common Stock 64125C109 48,643 -18,916 2,462
2019-07-29 2016-06-30 13F/A-1 NEUROCINE BIO Common Stock 64125C109 67,684 67,684 3,076 0.0065
2016-08-15 2016-06-30 13F NEUROCINE BIO Common Stock 64125C109 67,559 67,559 3,070
2019-07-25 2016-03-31 13F/A-1 NEUROCINE BIO Common Stock 64125C109 0 -3,355 -100.00 0 -100.00
2019-07-24 2015-12-31 13F/A-1 NEUROCINE BIO Common Stock 64125C109 3,355 -2,525 -42.94 189 -18.88 0.0004
2016-02-12 2015-12-31 13F NEUROCINE BIO Common Stock 64125C109 3,355 -2,525 189
2019-07-15 2015-09-30 13F/A-1 NEUROCINE BIO Common Stock 64125C109 5,880 1,490 33.94 233 11.48 0.0006
2015-11-13 2015-09-30 13F NEUROCINE BIO Common Stock 64125C109 5,880 1,490 233
2019-07-08 2015-06-30 13F/A-1 NEUROCINE BIO Common Stock 64125C109 4,390 425 10.72 209 33.12 0.0004
2015-08-13 2015-06-30 13F NEUROCINE BIO Common Stock 64125C109 4,390 425 209
2015-06-09 2015-03-31 13F/A-1 NEUROCINE BIO Common Stock 64125C109 3,965 3,965 157 0.0003
2015-05-15 2015-03-31 13F NEUROCINE BIO Common Stock 64125C109 3,965 157 0.0003
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.